Immediate complications and subsequent reproductive outcome after medical abortion: hospital based cross sectional study
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20151297Keywords:
Medical abortion, Reproductive outcome, Complications, Family planningAbstract
Background: Medical abortion is considered to be a safe, effective and reliable method for termination of pregnancy. The procedure has stood the test of time very well over the last 10 years in terms of results and immediate complications but there are not many reports regarding the subsequent reproductive outcome of these women. Thus, it was decided to conduct a study with special focus on subsequent reproductive outcome in women undergoing medical abortion. The objectives of the study were to determine the source of health care provider for women seeking medical abortion, to study immediate complications of medical abortion, to study acceptance of family planning methods post medical abortion in the study subjects and to study subsequent reproductive outcomes in women who underwent medical abortion.
Methods: A cross sectional institution based study was conducted after ethics committee approval in the Obstetrics and Gynecology outpatient department of a tertiary care institute from January 2014 to December 2014. 94 newly registered patients in the age group of 18-35 years who came to the Obstetrics and Gynecology OPD during the study period were interviewed. Amongst these those who have undergone medical abortion in the period between 2010 and 2011 and were willing to participate in the study were enrolled. Diagnosed cases of Diabetes Mellitus, Hypertension and any other major medical or surgical illness were excluded from the study.
Study subjects were interviewed with a revalidated, pretested semi structured Questionnaire with due privacy to maintain confidentiality. The data was analyzed by SPSS version 16 software.
Results: 13.8% study subjects took their medicines from chemists without consulting any medical professional and 9.5% of them were prescribed these medicines by general practitioners. Prevalence of immediate complications that is incomplete abortion, need for surgical evacuation and excessive bleeding in the study were 17%, 11.7% and 1.1% respectively. Proportion of women who accepted family planning post medical abortion was 62.8%. Prevalence of subsequent reproductive outcomes in females who did not use permanent method of sterilization or got copper T inserted were infertility (7.1%), abortion (8.9%), ectopic pregnancy (3.6%), PIH (10.7%), IUGR (3.6%) and preterm labour (10.7%).
Conclusions: Medical abortion using Mifepristone and Misoprostol is a reliable and safe method of termination of early pregnancy (up to 7 weeks period of gestation). These findings are relevant while counseling patients for medical abortion.References
Charles W, Ann P. Alternative Measure for Unmet Need for Family Planning in Developing Countries. Int Fam Plan Perspect. 2000;7(4):126-35.
Ashoke S, John S. and Jayanti MT. The KAP-gap in Nepal: Reasons for non-use of Contraception Among couples with Unmet Need for Family Planning. Asia-Pacific Population Journal. 2000;6(1):25-38.
Jones RK, Zolna MR, Henshaw SK, Finer LB. Abotion in the United States: incidence and access to services, 2005. Perspect Sex Reprod Health. 2008;40:6-16.
National institute for Health and Welfare: Induced abortions. Available at: Retrieved 2009.
The National Board of Health and Welfare. 2009.
Department of Health. 2009.
Grimes DA, Risk of Mifepristone abortion on context. Contraception. 2009;71:161.
Thong KJ, Bair DT. Induction of abortion with Mifepristone and Misoprostol in early pregnancy. Br J ObstetGynaecol. 1992;99,1004-7.
Spitz IM, Bardin CW, Benton L, Robbins A. Early pregnancy termination with Mifepristone and Misoprostol in the United Stated. New Eng J. Med 1998;338:1241-7.
Atrash HK, Strauss LT, Kendrick JS, Skjeldestad FE, Ahn YW. The relation between induced abortion and ectopic pregnancy. Obstetrics and Gynaecology. 1997;89(4):512-8.
GAM C et al, Reproductive outcome after medical and surgical abortion. International Journal Gynecol Obstet. 2008;87(9):713-8.
Schaff EA, Eisinger SH, Stadalius LS, Franks P, Gore BZ, Poppema S. Low dose Mifepristone 200 mg and vaginal Misoprostol for abortion, Contraception. 1999;59:1-6.
Schaff EA, Eisinger SH, Stadalius LS, Franks P. Vaginal Misoprostol administered at home after Mifepristone (RU 486) for abortion. J Fam Pract. 1997;44:353-60.
Mckinley C, Thong KJ, Baird DT. The effect of dose of Mifepristone and gestation on the efficacy of medical abortion with Mifepristone and Misoprostol. Hum Reprod.1993;8:1502-5.
Fiala V, Gemzel-Danielson K (2006) Review of medical abortion using Mifepristone in combination with a Prostaglandin analogue. Contraception. 2006;74(1):66-86.
Niinimaki et al. Complications of Medical and surgical abortion. Vol.114, no.4, October 20.
Sitruk Ware R. Mifepristone and Misoprostol sequential regimen side effects, complications and safety. Contraception. 2006;74:48-55.
Kahn JG, Becker BJ, Maclsaac L, et al. The efficacy of medical abortion: a meta-analysis. Contraception. 2000;61:29-40.
Virk J, Zhang J, Olsen J. Medical abortion and the risk of subsequent adverse pregnancy outcomes. New England Journal of Medicine.
;357(7):648-53.
Bouyer J, Coste J, Shojaei T. Risk Factors for ectopic pregnancy: a comprehensive analysis based on a large case - control, population based study in France. Am J Epidemiol. 2003;157:185-94.
Antonisamy B, Sivaram M, Richard J, Rao PSS: Trends in Intra-uterine Growth in single live births in Southern India. J Trap Pediatr. 1996,42:339-41.
Pinheiro A, David A, Joseph B: Pregnancy weight gain and its correlation to birth weight. Indian J Med Science. 2001;55:266-70.
Chen A, Yuan W, Meirik, O. Mifepristone induced early abortion and outcome of subsequent wanted pregnancy. Am J Epidemiol. 2004;160:110-7.
Jacky Boivin, Laura Bunting, John A Collins, Karl G Nygren. International estimates of Infertility prevelance and Treatment seeking: Potential need and demand for Infertility Medical Care. Hum. Reprod. 2007;22(6):1506-12.
